150 related articles for article (PubMed ID: 10504057)
1. Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin.
Singh RK; Varney ML; Bucana CD; Johansson SL
Melanoma Res; 1999 Aug; 9(4):383-7. PubMed ID: 10504057
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-8 in the initiation and progression of human cutaneous melanoma.
Gutman M; Even-Sapir E; Merimsky O; Trejo L; Klausner JM; Lev-Chelouche D
Anticancer Res; 2002; 22(6A):3395-8. PubMed ID: 12530093
[TBL] [Abstract][Full Text] [Related]
3. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
4. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
[TBL] [Abstract][Full Text] [Related]
5. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.
Yang P; Farkas DL; Kirkwood JM; Abernethy JL; Edington HD; Becker D
Mol Med; 1999 Dec; 5(12):785-94. PubMed ID: 10666478
[TBL] [Abstract][Full Text] [Related]
6. Expression of neurotrophins and their receptors in pigment cell lesions of the skin.
Innominato PF; Libbrecht L; van den Oord JJ
J Pathol; 2001 May; 194(1):95-100. PubMed ID: 11329147
[TBL] [Abstract][Full Text] [Related]
7. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8.
Schaider H; Oka M; Bogenrieder T; Nesbit M; Satyamoorthy K; Berking C; Matsushima K; Herlyn M
Int J Cancer; 2003 Jan; 103(3):335-43. PubMed ID: 12471616
[TBL] [Abstract][Full Text] [Related]
8. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness.
Kunz M; Hartmann A; Flory E; Toksoy A; Koczan D; Thiesen HJ; Mukaida N; Neumann M; Rapp UR; Bröcker EB; Gillitzer R
Am J Pathol; 1999 Sep; 155(3):753-63. PubMed ID: 10487833
[TBL] [Abstract][Full Text] [Related]
9. IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.
Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
Mod Pathol; 2011 Jun; 24(6):801-9. PubMed ID: 21317876
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions.
Dummer W; Bastian BC; Ernst N; Schänzle C; Schwaaf A; Bröcker EB
Int J Cancer; 1996 May; 66(5):607-10. PubMed ID: 8647620
[TBL] [Abstract][Full Text] [Related]
11. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels.
Bánfalvi T; Udvarhelyi N; Orosz Z; Gergye M; Gilde K; Tímár J
Oncology; 2003; 64(4):374-9. PubMed ID: 12759535
[TBL] [Abstract][Full Text] [Related]
12. In vivo human melanoma cytokine production: inverse correlation of GM-CSF production with tumor depth.
Hensley C; Spitzler S; McAlpine BE; Lynn M; Ansel JC; Solomon AR; Armstrong CA
Exp Dermatol; 1998 Dec; 7(6):335-41. PubMed ID: 9858136
[TBL] [Abstract][Full Text] [Related]
13. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract][Full Text] [Related]
14. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-8 in tumor growth and metastasis of human melanoma.
Bar-Eli M
Pathobiology; 1999; 67(1):12-8. PubMed ID: 9873223
[TBL] [Abstract][Full Text] [Related]
16. Loss of beta-catenin expression associated with disease progression in malignant melanoma.
Kageshita T; Hamby CV; Ishihara T; Matsumoto K; Saida T; Ono T
Br J Dermatol; 2001 Aug; 145(2):210-6. PubMed ID: 11531781
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
[TBL] [Abstract][Full Text] [Related]
18. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.
Sanders DS; Blessing K; Hassan GA; Bruton R; Marsden JR; Jankowski J
Mol Pathol; 1999 Jun; 52(3):151-7. PubMed ID: 10621837
[TBL] [Abstract][Full Text] [Related]
19. Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasize.
Abramova L; Slingluff CL; Patterson JW
J Cutan Pathol; 2002 Aug; 29(7):407-14. PubMed ID: 12139635
[TBL] [Abstract][Full Text] [Related]
20. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
